Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C496
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
LIVERTOX |
731
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
NDF-RT |
N0000171009
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
WHO-VATC |
QV03AF08
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
NDF-RT |
N0000175671
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
NDF-RT |
N0000171009
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
NDF-RT |
N0000171009
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
KEPIVANCE (AUTHORIZED: MUCOSITIS)
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
WHO-ATC |
V03AF08
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
FDA ORPHAN DRUG |
130699
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
||
|
NDF-RT |
N0000175675
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB21058
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
C2455
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
6954
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
NN-06
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
DB00039
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
Palifermin
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
4804
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201821
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
196319
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | RxNorm | ||
|
162394-19-6
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
100000089579
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
8186
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
QMS40680K6
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
QMS40680K6
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | |||
|
m8356
Created by
admin on Mon Mar 31 20:44:43 GMT 2025 , Edited by admin on Mon Mar 31 20:44:43 GMT 2025
|
PRIMARY | Merck Index |
ACTIVE MOIETY